Denis Favier

Plintron, Konic and HMD announce a strategic handset partnership to enhance customer experience

Retrieved on: 
Wednesday, November 9, 2022
1,000,000, Growth, General manager, MercadoLibre, MVNO, Nokia, Mexican, C30, Plintron, HMD, Denis Favier, OMV, Partnership, World, MEXICO, Year, MVNA, Mobile phone, Drug, Konice

MEXICO CITY, Nov. 9, 2022 /PRNewswire/ --HMD Mexico and Konic, an MVNO powered by Plintron, have announced a strategic partnership where a Konic SIM card with 4 months unlimited data usage will be offered with select Nokia handset models.

Key Points: 
  • MEXICO CITY, Nov. 9, 2022 /PRNewswire/ --HMD Mexico and Konic, an MVNO powered by Plintron, have announced a strategic partnership where a Konic SIM card with 4 months unlimited data usage will be offered with select Nokia handset models.
  • Ali Banuelos, HMD General Manager Mexico said, "We continuously make efforts to improve products for our clients.
  • This initiative allows us to tap into the strong growing MVNO segment in Mexico and we are glad to jointly operate this with our partners Plintron and Konic."
  • The General Manager of Konic, Fernando Rodriguez, has been pleasantly surprised by the popularity of the bundle.

Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical to commercialize Avacc 3 - an OMV based whooping cough vaccine

Retrieved on: 
Monday, May 2, 2022
Diarrhea, WHO, R, Protein, Antigen, OMV, Vaccine, Death, Infection, Fever, Tetanus, Shigellosis, Recombinant, Whooping cough, COVID-19, CHO, Bacteria, Pneumonia, Toxicity, Technology, University, Toxicology, Cough, China Biologic Products, Profile, Vomiting, SZSE, Meningitis, Respiratory disease, Marketing, Bill & Melinda Gates Foundation, Influenza, DTP, CDMO, Immunology, Diagnosis, Bordetella pertussis, DPT, Disease, Denis Favier, Pharmaceutical industry, Trevor Flugge, Diphtheria, Haemophilus influenzae

Under the terms of this agreement Zhifei Lvzhu will receive an exclusive license for the Chinese territory and non-exclusive for Africa, South America and selected Asian countries.

Key Points: 
  • Under the terms of this agreement Zhifei Lvzhu will receive an exclusive license for the Chinese territory and non-exclusive for Africa, South America and selected Asian countries.
  • Intravacc's Avacc 3, a homologous Bordetella pertussis candidate vaccine based on Intravacc's OMV platform, induces a strong systemic immune response.
  • Since 2008, over 110 million doses of vaccines producedby Zhifei Lvzhu have being given to people needed worldwide.
  • Zhifei Lvzhu is a wholly owned subsidiary of ChongqingZhifei Biological ProductsCo., Ltd. (SZSE: 300122, "Zhifei" for short), a leading vaccine supplier and service provider globally.

Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical to commercialize Avacc 3 - an OMV based whooping cough vaccine

Retrieved on: 
Monday, May 2, 2022
Diarrhea, WHO, R, Protein, Antigen, OMV, Vaccine, Death, Infection, Fever, Tetanus, Shigellosis, Recombinant, Whooping cough, COVID-19, CHO, Bacteria, Pneumonia, Toxicity, Technology, University, Toxicology, Cough, China Biologic Products, Profile, Vomiting, SZSE, Meningitis, Respiratory disease, Marketing, Bill & Melinda Gates Foundation, Influenza, DTP, CDMO, Immunology, Diagnosis, Bordetella pertussis, DPT, Disease, Denis Favier, Pharmaceutical industry, Trevor Flugge, Diphtheria, Haemophilus influenzae

Under the terms of this agreement Zhifei Lvzhu will receive an exclusive license for the Chinese territory and non-exclusive for Africa, South America and selected Asian countries.

Key Points: 
  • Under the terms of this agreement Zhifei Lvzhu will receive an exclusive license for the Chinese territory and non-exclusive for Africa, South America and selected Asian countries.
  • Intravacc's Avacc 3, a homologous Bordetella pertussis candidate vaccine based on Intravacc's OMV platform, induces a strong systemic immune response.
  • Since 2008, over 110 million doses of vaccines producedby Zhifei Lvzhu have being given to people needed worldwide.
  • Zhifei Lvzhu is a wholly owned subsidiary of ChongqingZhifei Biological ProductsCo., Ltd. (SZSE: 300122, "Zhifei" for short), a leading vaccine supplier and service provider globally.